中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
24期
3357-3358
,共2页
汪学智%王琳%夏凡%容芳%黄鹏宇
汪學智%王琳%夏凡%容芳%黃鵬宇
왕학지%왕림%하범%용방%황붕우
肺结核%治疗方式%利福平%老年
肺結覈%治療方式%利福平%老年
폐결핵%치료방식%리복평%노년
Pulmonary tuberculosis%Treatment way%Rifampicin%Elder
目的 比较初治菌阳老年肺结核患者使用标准化疗方案时,静脉与口服两种不同方法应用利福平的疗效和依从性.方法 将100例初治菌阳老年肺结核患者,随机分为治疗组、对照组,强化期分别用HEZ加利福平注射液和HEZ加利福平胶囊方案治疗.分另观察消化道反应、肝功能异常率、结核症状好转率、痰菌阴转率、X线胸片吸收率.结果 治疗组与对照组3 d内消化道反应率分别为14%和82%(P<0.05);1周末肝功能异常率分别为16%和12%(P>0.05);2周末肝功能异常率分别为36%和30%(P>0.05);1周内结核症状好转率分别为96%和70%(P<0.05;2周末胸片显吸率分别为80%和32%(P<0.05);2月末痰涂片阴转率分别为52%和34%(P>0.05);6月末痰涂片阴转率分别为96%和82%(P<0.05);疗程内方案更改率分别为14%和82%(P<0.05).结论 初治老年肺结核患者强化期静脉较口服应用利福平疗效指标优化,消化道反应减少,肝功能异常发生率无明显增加,标准方案治疗依从性显著提高.
目的 比較初治菌暘老年肺結覈患者使用標準化療方案時,靜脈與口服兩種不同方法應用利福平的療效和依從性.方法 將100例初治菌暘老年肺結覈患者,隨機分為治療組、對照組,彊化期分彆用HEZ加利福平註射液和HEZ加利福平膠囊方案治療.分另觀察消化道反應、肝功能異常率、結覈癥狀好轉率、痰菌陰轉率、X線胸片吸收率.結果 治療組與對照組3 d內消化道反應率分彆為14%和82%(P<0.05);1週末肝功能異常率分彆為16%和12%(P>0.05);2週末肝功能異常率分彆為36%和30%(P>0.05);1週內結覈癥狀好轉率分彆為96%和70%(P<0.05;2週末胸片顯吸率分彆為80%和32%(P<0.05);2月末痰塗片陰轉率分彆為52%和34%(P>0.05);6月末痰塗片陰轉率分彆為96%和82%(P<0.05);療程內方案更改率分彆為14%和82%(P<0.05).結論 初治老年肺結覈患者彊化期靜脈較口服應用利福平療效指標優化,消化道反應減少,肝功能異常髮生率無明顯增加,標準方案治療依從性顯著提高.
목적 비교초치균양노년폐결핵환자사용표준화료방안시,정맥여구복량충불동방법응용리복평적료효화의종성.방법 장100례초치균양노년폐결핵환자,수궤분위치료조、대조조,강화기분별용HEZ가리복평주사액화HEZ가리복평효낭방안치료.분령관찰소화도반응、간공능이상솔、결핵증상호전솔、담균음전솔、X선흉편흡수솔.결과 치료조여대조조3 d내소화도반응솔분별위14%화82%(P<0.05);1주말간공능이상솔분별위16%화12%(P>0.05);2주말간공능이상솔분별위36%화30%(P>0.05);1주내결핵증상호전솔분별위96%화70%(P<0.05;2주말흉편현흡솔분별위80%화32%(P<0.05);2월말담도편음전솔분별위52%화34%(P>0.05);6월말담도편음전솔분별위96%화82%(P<0.05);료정내방안경개솔분별위14%화82%(P<0.05).결론 초치노년폐결핵환자강화기정맥교구복응용리복평료효지표우화,소화도반응감소,간공능이상발생솔무명현증가,표준방안치료의종성현저제고.
Objective To compare the effect and compliance of Rifampicin by vein and oral in treating pulmonary tuberculosis in elderly patients who were primary treated and had positive sputum. Methods A total of 100 first-time smear-positive pulmonary tuberculosis patients were randomly divided into two groups, the treatment group and the control group,with 50 cases in each group. During the observation enhancement period,patients of the treatment group were given HZE added rifampin inoculation fluid and HEZ plus rifampin capsules for the control group.The indicators were recorded, such as:the rate of digestive discomfort, liver digfunction ,symptom improvement, sputum smear negative conversion at the end of the second month and chest X-ray improvement. Results In therapy group and control group,the rate of digestive discomfort was 14% and 82% respectively,P <0. 05 ;the rate of liver disfunction at the first weekend was 16% and 12% respectively(P > 0. 05 ) ;The rate of liver disfunction at the second weekend was 36% and 30% respectively(P >0. 05) ;The rate of the symptom improvement was 96% and 70% respectively ( P < 0. 05 ) ;The rate of improvement remarkably in chest film was 80% and 32% respectively( P < 0. 05 ) ;The rate of sputum smear negative conversion at the end of the second month was 52% and 34% ,P >0. 05 ;the rate of.sputum smear negative conversion at the end of the sixth month was 96% and 82% (P < 0. 05 ) ;The rate of chemotherapy formula changed during the therapy was 14% and 82% ( P < 0. 05). Conclusion The Rifampicin was used by vein in elderly PTB that primary treated and got positive sputum could get better effect indexes,less side effect in digestive tract,similar liver disfunction and fine compliance to the standardized chemotherapy formula.